FDA.reportPublic FDA data

Nasoclenz

Manufacturer
Silicon Valley Innovations, Inc.
Effective date
2021-07-07
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:44:45

Label at a glance#

ProductNasoclenz
Active ingredientBENZALKONIUM CHLORIDE
Label structure12 sections

Indications and uses

Helps reduce bacteria that can cause skin infections Antiseptic preparation to decrease bacteria on skin

Dosage and administration

Open gel packets and apply gel to tip of applicator Insert tip with gel into the right nostril, rotating it a few times, then rotate it in the opposite direction. Using a second applicator, apply gel to tip and repeat step #2 in the left nostril Do not blow nose immediately after use. Use every 4-8 hours as needed Children under age 12 use adult supervision

Storage and handling

Best if stored at 59-84F (19-29C)

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzalkonium chloride (0.13%)

Uses

OTC - PURPOSE SECTION

  • Helps reduce bacteria that can cause skin infections

INDICATIONS & USAGE SECTION

  • Antiseptic preparation to decrease bacteria on skin

Warnings

WARNINGS SECTION

For external use only.

Do Not Use

OTC - DO NOT USE SECTION

  • If you are allegic to any of the ingredients
  • In or near eyes
  • On children under 2 years of age

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • Deep or puncture wounds
  • Serious burns

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • Irritation, swelling, pain or other allergic reaction develops
  • Infection occurs

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away

Directions

INSTRUCTIONS FOR USE SECTION

  1. Open gel packets and apply gel to tip of applicator
  2. Insert tip with gel into the right nostril, rotating it a few times, then rotate it in the opposite direction.
  3. Using a second applicator, apply gel to tip and repeat step #2 in the left nostril
  4. Do not blow nose immediately after use.

DOSAGE & ADMINISTRATION SECTION

  • Use every 4-8 hours as needed
  • Children under age 12 use adult supervision

Other information

STORAGE AND HANDLING SECTION

Best if stored at 59-84F (19-29C)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carbomer, Diethylene Glycol Monoethyl Ether, Glycerin, Propylene Glycol, Triethanolamine, Water

Questions?

OTC - QUESTIONS SECTION

Call 1-844-4MY-NASO (1-844-469-6276) M-F 9am to 5pm PST

Nasoclenz.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display PanelPrincipal Display Panel

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
81900-013-01Nasoclenz40 in 1 BOXGEL401
81900-013-01Nasoclenz1 in 1 POUCHGEL11
81900-013-02Nasoclenz1 in 1 POUCHGEL11
81900-013-02Nasoclenz8 in 1 BOXGEL81

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
81900-013NASOCLENZ (BENZALKONIUM CHLORIDE 0.13%) GEL [SILICON VALLEY INNOVATIONS, INC.]1Legacy NDC, 4 package rows20211104_c68d426c-64be-d2d2-e053-2a95a90a90da.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81900-01381900-013-02, 81900-013-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Name, UNII, Kind table
NameUNIIKind
DIETHYLENE GLYCOL MONOETHYL ETHERA1A1I8X02BIACT
WATER059QF0KO0RIACT
TROLAMINE9O3K93S3TKIACT
BENZALKONIUM CHLORIDEF5UM2KM3W7ACTIB
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)F68VH75CJCIACT
PROPYLENE GLYCOL6DC9Q167V3IACT
GLYCERINPDC6A3C0OXIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c68d426c-64bf-d2d2-e053-2a95a90a90dac68d426c-64be-d2d2-e053-2a95a90a90da2021-07-07WarningsExact identifier
spl id: c68d426c-64bf-d2d2-e053-2a95a90a90da
spl set id: c68d426c-64be-d2d2-e053-2a95a90a90da

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.